Figure 6.
Effect of the GHRH-R antagonist MIA-690 (5 μg/day), Gefitinib (100 mg/Kg/day), and their combination on the expression of GHRH, GHRH-R, pEGFR, pHER2, MMP2, and MMP9. The immunoexpression was observed in histological sections from PC-3 tumours. For all figures, original magnification scale bar is 30 μm.